These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 35781779)

  • 1. An 82-year-old woman with new onset of multiple purple-reddish nodules during treatment with abatacept for rheumatoid arthritis.
    Ambrogio F; Laface C; Perosa F; Lospalluti L; Ranieri G; De Prezzo S; Prete M; Cazzato G; Guarneri F; Romita P; Foti C
    Intern Emerg Med; 2022 Nov; 17(8):2339-2341. PubMed ID: 35781779
    [No Abstract]   [Full Text] [Related]  

  • 2. Kaposi's sarcoma after T-cell costimulation blockade with abatacept in rheumatoid arthritis: a case report.
    Olivo D; Grembiale RD; Tallarigo F; Russo E; De Sarro G; Ursini F
    J Clin Pharm Ther; 2017 Jun; 42(3):367-369. PubMed ID: 28262965
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Case of Pyoderma Gangrenosum in a Patient with Rheumatoid Arthritis Treated with Abatacept.
    Akahoshi-Ikeda M; Yoshizawa S; Motoshita J; Furue M; Takeuchi S
    Acta Derm Venereol; 2016 Aug; 96(6):822-3. PubMed ID: 26912455
    [No Abstract]   [Full Text] [Related]  

  • 4. First report of membranous nephropathy and systemic lupus erythematosus associated with abatacept in rheumatoid arthritis.
    Asami Y; Ishiguro H; Ueda A; Nakajima H
    Clin Exp Rheumatol; 2016; 34(6):1122. PubMed ID: 27462998
    [No Abstract]   [Full Text] [Related]  

  • 5. Cryptococcal Meningitis in a Patient With Rheumatoid Arthritis Treated With Abatacept.
    Mino M; Yamasaki M; Nabeshima S; Fujimoto Y; Kurushima H; Taniwaki M; Matsumoto N; Kawamoto K; Izumi Y; Otohara M; Hattori N
    J Clin Rheumatol; 2021 Dec; 27(8S):S701-S702. PubMed ID: 33065627
    [No Abstract]   [Full Text] [Related]  

  • 6. A Case of Disseminated Histoplasmosis in a Patient with Rheumatoid Arthritis on Abatacept.
    Jain N; Doyon JB; Lazarus JE; Schaefer IM; Johncilla ME; Agoston AT; Dalal AK; Velásquez GE
    J Gen Intern Med; 2018 May; 33(5):769-772. PubMed ID: 29532302
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retention and clinical response to abatacept in patients with rheumatoid arthritis: an Italian perspective.
    Galeazzi M; Alten R; Chartier M; Elbez Y; Fusaro E; Le Bars M; Lorenz HM; Pagano Mariano G; Muratore M; Nüßlein HG; Patanè G
    Clin Exp Rheumatol; 2018; 36(5):935-936. PubMed ID: 29600933
    [No Abstract]   [Full Text] [Related]  

  • 8. Psoriatic skin lesions induced by abatacept: Case report and review of the published work.
    Ueda-Hayakawa I; Nguyen Thi Hong C; Ueki Y; Kambe N; Okamoto H
    J Dermatol; 2017 Jul; 44(7):845-846. PubMed ID: 27542572
    [No Abstract]   [Full Text] [Related]  

  • 9. Rosacea and abatacept: the first report of a possible correlation.
    Lo Schiavo A; Tirri R; Peccerillo F; Abbondanza C; Russo B; Caccavale S
    G Ital Dermatol Venereol; 2016 Feb; 151(1):123. PubMed ID: 26924033
    [No Abstract]   [Full Text] [Related]  

  • 10. Atopic Dermatitis Flare during Abatacept Therapy.
    Stinco G; Bergamo S; Frattasio A; di Meo N; Trevisan G
    J Cutan Med Surg; 2014 Nov; 18(6):369-70. PubMed ID: 25348756
    [No Abstract]   [Full Text] [Related]  

  • 11. Postmarketing surveillance of the safety and effectiveness of abatacept in Japanese patients with rheumatoid arthritis.
    Harigai M; Ishiguro N; Inokuma S; Mimori T; Ryu J; Takei S; Takeuchi T; Tanaka Y; Takasaki Y; Yamanaka H; Watanabe M; Tamada H; Koike T
    Mod Rheumatol; 2016 Jul; 26(4):491-8. PubMed ID: 26635183
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term deterioration of interstitial lung disease in patients with rheumatoid arthritis treated with abatacept.
    Mochizuki T; Ikari K; Yano K; Sato M; Okazaki K
    Mod Rheumatol; 2019 May; 29(3):413-417. PubMed ID: 29798700
    [TBL] [Abstract][Full Text] [Related]  

  • 13. On-drug and drug-free remission by baseline symptom duration: abatacept with methotrexate in patients with early rheumatoid arthritis.
    Bykerk VP; Burmester GR; Combe BG; Furst DE; Huizinga TWJ; Ahmad HA; Emery P
    Rheumatol Int; 2018 Dec; 38(12):2225-2231. PubMed ID: 30341453
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New onset of rheumatoid vasculitis during abatacept therapy and subsequent improvement after rituximab.
    Carvajal Alegria G; Uguen A; Genestet S; Marcorelles P; Saraux A; Cornec D
    Joint Bone Spine; 2016 Oct; 83(5):605-6. PubMed ID: 27052429
    [No Abstract]   [Full Text] [Related]  

  • 15. No difference in cardiovascular risk of tocilizumab versus abatacept for rheumatoid arthritis: A multi-database cohort study.
    Kim SC; Solomon DH; Rogers JR; Gale S; Klearman M; Sarsour K; Schneeweiss S
    Semin Arthritis Rheum; 2018 Dec; 48(3):399-405. PubMed ID: 29673963
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Up to 5-year retention of abatacept in Belgian patients with moderate-to-severe rheumatoid arthritis: a sub-analysis of the international, observational ACTION study.
    Westhovens R; Connolly SE; Margaux J; Vanden Berghe M; Maertens M; Van den Berghe M; Elbez Y; Chartier M; Baeke F; Robert S; Malaise M
    Rheumatol Int; 2020 Sep; 40(9):1409-1421. PubMed ID: 32556473
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictive risk factors of serious infections in patients with rheumatoid arthritis treated with abatacept in common practice: results from the Orencia and Rheumatoid Arthritis (ORA) registry.
    Salmon JH; Gottenberg JE; Ravaud P; Cantagrel A; Combe B; Flipo RM; Schaeverbeke T; Houvenagel E; Gaudin P; Loeuille D; Rist S; Dougados M; Sibilia J; Le Loët X; Meyer O; Solau-Gervais E; Marcelli C; Bardin T; Pane I; Baron G; Perrodeau E; Mariette X;
    Ann Rheum Dis; 2016 Jun; 75(6):1108-13. PubMed ID: 26048170
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectiveness of abatacept for patients with Sjögren's syndrome associated with rheumatoid arthritis. An open label, multicenter, one-year, prospective study: ROSE (Rheumatoid Arthritis with Orencia Trial toward Sjögren's syndrome Endocrinopathy) trial.
    Tsuboi H; Matsumoto I; Hagiwara S; Hirota T; Takahashi H; Ebe H; Yokosawa M; Yagishita M; Takahashi H; Kurata I; Ohyama A; Honda F; Asashima H; Miki H; Umeda N; Kondo Y; Hirata S; Saito K; Tanaka Y; Horai Y; Nakamura H; Kawakami A; Sumida T
    Mod Rheumatol; 2016 Nov; 26(6):891-899. PubMed ID: 27459020
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rapid development of severe acute respiratory distress syndrome after abatacept treatment in a patient with rheumatoid arthritis.
    Gower J; Labarca G; Enos D; Nova-Lamperti E
    BMJ Case Rep; 2020 Apr; 13(4):. PubMed ID: 32265206
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trial of Upadacitinib or Abatacept in Rheumatoid Arthritis.
    Rubbert-Roth A; Enejosa J; Pangan AL; Haraoui B; Rischmueller M; Khan N; Zhang Y; Martin N; Xavier RM
    N Engl J Med; 2020 Oct; 383(16):1511-1521. PubMed ID: 33053283
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.